Dr. Matthew Taylor, MD
Claim this profileProvidence Portland Medical Center
Studies Melanoma
Studies Squamous Cell Carcinoma
18 reported clinical trials
32 drugs studied
Area of expertise
1Melanoma
Stage IV
Stage III
2Squamous Cell Carcinoma
Stage IV
PD-L1 positive
Stage III
Affiliated Hospitals
Clinical Trials Matthew Taylor, MD is currently running
Encorafenib + Binimetinib +/- Nivolumab
for Thyroid Cancer
This trial studies how well encorafenib and binimetinib, with or without nivolumab, work in treating a specific type of thyroid cancer that has spread and doesn't respond to usual treatments. The drugs aim to stop cancer growth and help the immune system fight the cancer. Encorafenib and binimetinib are used in combination to treat BRAF V600 mutation-positive melanoma, showing improved response rates and survival.
Recruiting1 award Phase 211 criteria
EP0031
for Cancer
The aim of this study is to assess the safety, side effects and effectiveness of EP0031 in patients with advanced RET-altered malignancies
Recruiting1 award Phase 1 & 2
More about Matthew Taylor, MD
Clinical Trial Related3 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 13 Active Clinical TrialsTreatments Matthew Taylor, MD has experience with
- Pembrolizumab
- Nivolumab
- Cemiplimab
- Cabozantinib
- Placebo
- Sham Device
Breakdown of trials Matthew Taylor, MD has run
Melanoma
Squamous Cell Carcinoma
Non-Small Cell Lung Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Matthew Taylor, MD specialize in?
Matthew Taylor, MD focuses on Melanoma and Squamous Cell Carcinoma. In particular, much of their work with Melanoma has involved Stage IV patients, or patients who are Stage III.
Is Matthew Taylor, MD currently recruiting for clinical trials?
Yes, Matthew Taylor, MD is currently recruiting for 13 clinical trials in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Matthew Taylor, MD has studied deeply?
Yes, Matthew Taylor, MD has studied treatments such as Pembrolizumab, Nivolumab, Cemiplimab.
What is the best way to schedule an appointment with Matthew Taylor, MD?
Apply for one of the trials that Matthew Taylor, MD is conducting.
What is the office address of Matthew Taylor, MD?
The office of Matthew Taylor, MD is located at: Providence Portland Medical Center, Portland, Oregon 97213 United States. This is the address for their practice at the Providence Portland Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.